These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 33124553)

  • 21. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
    BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.
    Whiley DM; Trembizki E; Buckley C; Freeman K; Baird RW; Beaman M; Chen M; Donovan B; Kundu RL; Fairley CK; Guy R; Hogan T; Kaldor JM; Karimi M; Limnios A; Regan DG; Ryder N; Su JY; Ward J; Lahra MM
    Emerg Infect Dis; 2017 Sep; 23(9):1478-1485. PubMed ID: 28820128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
    Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M;
    BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.
    Brunner A; Nemes-Nikodem E; Mihalik N; Marschalko M; Karpati S; Ostorhazi E
    BMC Infect Dis; 2014 Aug; 14():433. PubMed ID: 25098185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.
    Brittain C; Childs M; Duley L; Harding J; Hepburn T; Meakin G; Montgomery AA; Tan W; Ross JD
    Trials; 2016 Nov; 17(1):558. PubMed ID: 27881151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Background review for the '2020 European guideline for the diagnosis and treatment of gonorrhoea in adults'.
    Unemo M; Ross J; Serwin AB; Gomberg M; Cusini M; Jensen JS
    Int J STD AIDS; 2021 Feb; 32(2):108-126. PubMed ID: 33323071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study.
    Sánchez-Busó L; Cole MJ; Spiteri G; Day M; Jacobsson S; Golparian D; Sajedi N; Yeats CA; Abudahab K; Underwood A; Bluemel B; Aanensen DM; Unemo M;
    Lancet Microbe; 2022 Jun; 3(6):e452-e463. PubMed ID: 35659907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic evaluation of antimicrobial resistance in curable sexually transmitted infections; a systematic review and a case study.
    Ayinde O; Ross JDC; Jackson L
    PLoS One; 2023; 18(10):e0292273. PubMed ID: 37856496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demographic and behavioural factors associated with antimicrobial susceptibility to azithromycin and ceftriaxone in
    Forster RF; Smith M; Cooper G; Brokenshire M; Roberts SA; McAuliffe GN
    Int J STD AIDS; 2021 Jan; 32(1):67-74. PubMed ID: 33198606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance and molecular epidemiological typing of Neisseria gonorrhoeae isolates from Kyrgyzstan in Central Asia, 2012 and 2017.
    Karymbaeva S; Boiko I; Jacobsson S; Mamaeva G; Ibraeva A; Usupova D; Golparian D; Unemo M
    BMC Infect Dis; 2021 Jun; 21(1):559. PubMed ID: 34118893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of multidrug-resistant
    Yuan Q; Li Y; Xiu L; Zhang C; Fu Y; Jiang C; Tang L; Peng J
    Emerg Microbes Infect; 2019; 8(1):1546-1549. PubMed ID: 31661379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonorrhoea treatment failure caused by a
    Eyre DW; Sanderson ND; Lord E; Regisford-Reimmer N; Chau K; Barker L; Morgan M; Newnham R; Golparian D; Unemo M; Crook DW; Peto TE; Hughes G; Cole MJ; Fifer H; Edwards A; Andersson MI
    Euro Surveill; 2018 Jul; 23(27):. PubMed ID: 29991383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae.
    Roy K; Wang SA; Meltzer MI
    Emerg Infect Dis; 2005 Aug; 11(8):1265-73. PubMed ID: 16102317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between In vitro susceptibility and treatment outcome with azithromycin in gonorrhoea: a prospective study.
    Khaki P; Bhalla P; Sharma A; Kumar V
    Indian J Med Microbiol; 2007 Oct; 25(4):354-7. PubMed ID: 18087084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011.
    Thakur SD; Araya P; Borthagaray G; Galarza P; Hernandez AL; Payares D; Sanabria Cruz OM; Carvallo ME; Corredor AH; Dillon JR
    Sex Transm Dis; 2017 Mar; 44(3):157-160. PubMed ID: 28178114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020.
    Al-Maslamani M; Elmagboul EBI; Puthiyottil A; Chemaitelly H; Varghese MK; Al Romaihi HE; Al-Thani MH; Al Khal A; Unemo M; Abu-Raddad LJ
    PLoS One; 2022; 17(3):e0264737. PubMed ID: 35235608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England.
    Chisholm SA; Wilson J; Alexander S; Tripodo F; Al-Shahib A; Schaefer U; Lythgow K; Fifer H
    Sex Transm Infect; 2016 Aug; 92(5):365-7. PubMed ID: 26601852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.